Prostatype Genomics AB

About:

Prostatype Genomics AB is a Med-tech company, that manufactures, markets and sells the prognostic gene test Prostatype.

Website: https://www.prostatypegenomics.com/

Top Investors: Sting

Description:

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene test Prostatype. By giving a comprehensive assessment of the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under-treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Total Funding Amount:

7.3M SEK

Headquarters Location:

Solna, Stockholms Lan, Sweden

Founded Date:

2007-01-01

Contact Email:

info(AT)prostatypegenomics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-04-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai